news
GlaxoSmithKline (GSK) and the University of Oxford will collaborate to…
2 December 2021 | By Anna Begley (Drug Target Review)
GlaxoSmithKline (GSK) and the University of Oxford will collaborate to investigate diseases using technologies such as functional genomics and machine learning.